certificates are easy to forge and the system does not check legitimacy. molecular oncology, professor lauren chung, highlights the challenges if we have, as we do differing rates vaccination across europe, that is going to create some problems. i think in terms of travel and we know that this more infectious variant is spreading. we know the various vaccine platforms that have been developed, including the are and platforms are being modified now and trial individuals to check that we will be able to generate even better protective community against barriers. and i guess it's a case of keeping an eye on levels of, of protection levels of antibodies. so there is a complication to vaccine. paul's falls, not only in terms of variance, but also one of the current big unknowns is how long does the protective immunity induced by vaccination actually last, we believe it to be more than 6 months. so there is an issue here about whether or not we're going to have to have some way of just measuring antibodies. it's not difficult or a test that you can do this very easily, but it may be that to keep vaccine